These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31816124)

  • 1. Echocardiographic and biomarker evidence of plasma volume expansion after short-term steroids administered orally in cats.
    Block CL; Oyama MA
    J Vet Intern Med; 2020 Jan; 34(1):29-34. PubMed ID: 31816124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Survival Time and Changes in NT-proBNP in Cats Treated for Congestive Heart Failure.
    Pierce KV; Rush JE; Freeman LM; Cunningham SM; Yang VK
    J Vet Intern Med; 2017 May; 31(3):678-684. PubMed ID: 28370373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR; Oyama MA; Reynolds C; Rush JE; DeFrancesco TC; Keene BW; Atkins CE; Macdonald KA; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Nguyenba TP; Lehmkuhl LB; Lefbom BK; Moise NS; Hogan DF
    J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of circulating amino terminal-pro-B-type natriuretic peptide concentration in dogs with respiratory distress attributable to congestive heart failure or primary pulmonary disease.
    Fine DM; DeClue AE; Reinero CR
    J Am Vet Med Assoc; 2008 Jun; 232(11):1674-9. PubMed ID: 18518809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats.
    Fox PR; Rush JE; Reynolds CA; Defrancesco TC; Keene BW; Atkins CE; Gordon SG; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Macdonald KA; Lehmkuhl LB; Nguyenba TP; Sydney Moise N; Lefbom BK; Hogan DF; Oyama MA
    J Vet Intern Med; 2011; 25(5):1010-6. PubMed ID: 21985136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of atenolol on NT-proBNP and troponin in asymptomatic cats with severe left ventricular hypertrophy because of hypertrophic cardiomyopathy: a pilot study.
    Jung SW; Kittleson MD
    J Vet Intern Med; 2011; 25(5):1044-9. PubMed ID: 21781160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats.
    Wess G; Daisenberger P; Mahling M; Hirschberger J; Hartmann K
    Vet Clin Pathol; 2011 Jun; 40(2):237-44. PubMed ID: 21434959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of a bedside test for N-terminal pro B-type natriuretic peptide (NT-proBNP) to differentiate cardiac from non-cardiac causes of pleural effusion in cats.
    Wurtinger G; Henrich E; Hildebrandt N; Wiedemann N; Schneider M; Hassdenteufel E
    BMC Vet Res; 2017 Dec; 13(1):394. PubMed ID: 29262821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of NT-pro-BNP assay on accuracy and confidence of general practitioners in diagnosing heart failure or respiratory disease in cats with respiratory signs.
    Singletary GE; Rush JE; Fox PR; Stepien RL; Oyama MA
    J Vet Intern Med; 2012; 26(3):542-6. PubMed ID: 22458368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prespecified therapy escalation on plasma NT-proBNP concentrations in dogs with stable congestive heart failure due to myxomatous mitral valve disease.
    Hezzell MJ; Block CL; Laughlin DS; Oyama MA
    J Vet Intern Med; 2018 Sep; 32(5):1509-1516. PubMed ID: 30216549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker changes with systolic anterior motion of the mitral valve in cats with hypertrophic cardiomyopathy.
    Seo J; Payne JR; Novo Matos J; Fong WW; Connolly DJ; Luis Fuentes V
    J Vet Intern Med; 2020 Sep; 34(5):1718-1727. PubMed ID: 32822105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of point-of-care thoracic ultrasound and NT-proBNP for the diagnosis of congestive heart failure in cats with respiratory distress.
    Ward JL; Lisciandro GR; Ware WA; Viall AK; Aona BD; Kurtz KA; Reina-Doreste Y; DeFrancesco TC
    J Vet Intern Med; 2018 Sep; 32(5):1530-1540. PubMed ID: 30216579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
    J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of circulating N-terminal pro B-type natriuretic peptide concentration to differentiate between cardiac from noncardiac causes of pleural effusion in cats.
    Hassdenteufel E; Henrich E; Hildebrandt N; Stosic A; Schneider M
    J Vet Emerg Crit Care (San Antonio); 2013; 23(4):416-22. PubMed ID: 23859335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the responsiveness of the Cats' Assessment Tool for Cardiac Health (CATCH) Questionnaire.
    Rush JE; Roderick KV; Freeman LM; Cunningham SM; Yang VK; Bulmer BJ; Antoon KN
    J Vet Cardiol; 2015 Dec; 17 Suppl 1():S341-8. PubMed ID: 26776591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic, hemodynamic, and echocardiographic effects of short-term oral administration of anti-inflammatory doses of prednisolone to systemically normal cats.
    Khelik IA; Berger DJ; Mochel JP; Seo YJ; Palerme JS; Ware WA; Ward JL
    Am J Vet Res; 2019 Aug; 80(8):743-755. PubMed ID: 31339769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure.
    Kanno N; Hori Y; Hidaka Y; Chikazawa S; Kanai K; Hoshi F; Itoh N
    J Vet Med Sci; 2016 May; 78(4):535-42. PubMed ID: 26607133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic significance of the plasma N-terminal pro-B-type natriuretic Peptide concentration in asymptomatic cats with cardiac enlargement.
    Tominaga Y; Miyagawa Y; Toda N; Takemura N
    J Vet Med Sci; 2011 Aug; 73(8):971-5. PubMed ID: 21467762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point-of-care N-terminal pro B-type natriuretic peptide assay to screen apparently healthy cats for cardiac disease in general practice.
    Lu TL; Côté E; Kuo YW; Wu HH; Wang WY; Hung YW
    J Vet Intern Med; 2021 Jul; 35(4):1663-1672. PubMed ID: 33993546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association of plasma amino-terminal pro-A-, B- and C-type natriuretic peptide levels with NYHA grade and echocardiographic derived parameters of cardiac function in heart failure patients].
    Zhao XY; Yang YJ; Zhang J; Kang LM; Wei BQ; Gao XJ; Lü R; Zhang CL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jun; 37(6):486-90. PubMed ID: 19927626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.